Business Standard

Wednesday, December 25, 2024 | 08:42 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Best of BS Opinion: The PSU conundrum, adulterated honey, and more

Here are the best of Business Standard's opinions for Monday

Coronavirus, vaccine, covid, drugs, clinical trials
Premium

Kanika Datta
The government is counting on a vaccine to bring life and the economy back on track but seroprevalance studies suggest that a significant share of the population has experienced Covid-19 and already has the antibodies. Rather than focusing on getting the vaccine out on scale, Ajay Shah argues here that the release of data on seroprevalence, created through scientific surveys in each city, every week, would be a more relevant path to normalcy. Other views look at the government’s demands on public sector units, the honey adulteration scandal and the jumbo antitrust suit against Facebook. Kanika Datta sums up the views

Along with

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in